BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 8387249)

  • 1. Protection against pseudorabies virus infection by intranasal vaccination of newborn pigs.
    McCaw MB; Xu J
    Am J Vet Res; 1993 Apr; 54(4):527-33. PubMed ID: 8387249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High- and low-challenge exposure doses used to compare intranasal and intramuscular administration of pseudorabies virus vaccine in passively immune pigs.
    Arellano PE; Morrison RB; Molitor TW; Thawley DG
    J Am Vet Med Assoc; 1992 Mar; 200(5):685-91. PubMed ID: 1314793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of active immunity in newborn pigs with colostral antibodies by vaccination with gIII-deleted PRV.
    Kit S; Kit M; McConnell S; Lawhorn B
    Acta Vet Hung; 1994; 42(2-3):319-30. PubMed ID: 7810426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal vaccination of pigs against pseudorabies: absence of vaccinal virus latency and failure to prevent latency of virulent virus.
    van Oirschot JT; Gielkens AL
    Am J Vet Res; 1984 Oct; 45(10):2099-103. PubMed ID: 6093645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine-induced T cell-mediated immunity plays a critical role in early protection against pseudorabies virus (suid herpes virus type 1) infection in pigs.
    van Rooij EM; de Bruin MG; de Visser YE; Middel WG; Boersma WJ; Bianchi AT
    Vet Immunol Immunopathol; 2004 May; 99(1-2):113-25. PubMed ID: 15113659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response of pigs inoculated with virulent pseudorabies virus and pigs inoculated with attenuated or inactivated pseudorabies virus vaccine before and after challenge exposure.
    Kelling CL; Staudinger WL; Rhodes MB
    Am J Vet Res; 1982 Dec; 43(12):2114-20. PubMed ID: 6299139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal vaccination of pigs against Aujeszky's disease: comparison with one or two doses of attenuated vaccines in pigs with high maternal antibody titres.
    Van Oirschot JT
    Res Vet Sci; 1987 Jan; 42(1):12-6. PubMed ID: 3029845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody response to glycoprotein I in maternally immune pigs exposed to a mildly virulent strain of pseudorabies virus.
    van Oirschot JT; Daus F; Kimman TG; van Zaane D
    Am J Vet Res; 1991 Nov; 52(11):1788-93. PubMed ID: 1664670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.
    Li X; Liu R; Tang H; Jin M; Chen H; Qian P
    Vaccine; 2008 May; 26(22):2714-22. PubMed ID: 18436351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A DNA vaccine coding for gB and gD of pseudorabies virus (suid herpes type 1) primes the immune system in the presence of maternal immunity more efficiently than conventional vaccines.
    van Rooij EM; Moonen-Leusen HW; de Visser YE; Middel WG; Boersma WJ; Bianchi AT
    Vaccine; 2006 Feb; 24(9):1264-73. PubMed ID: 16289276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine.
    Qian P; Li XM; Jin ML; Peng GQ; Chen HC
    Vaccine; 2004 Jun; 22(17-18):2129-36. PubMed ID: 15149769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abortion induced by cell-associated pseudorabies virus in vaccinated sows.
    Nauwynck HJ; Pensaert MB
    Am J Vet Res; 1992 Apr; 53(4):489-93. PubMed ID: 1316724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation in swine of a subunit vaccine against pseudorabies.
    Maes RK; Schutz JC
    Am J Vet Res; 1983 Jan; 44(1):123-5. PubMed ID: 6297337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of vaccination on lesion development in pseudorabies virus-challenged swine.
    Alva-Valdes R; Glock RD; Kluge JP; Keune CM
    Am J Vet Res; 1983 Apr; 44(4):588-95. PubMed ID: 6307084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination of swine with thymidine kinase-deficient mutants of pseudorabies virus.
    McGregor S; Easterday BC; Kaplan AS; Ben-Porat T
    Am J Vet Res; 1985 Jul; 46(7):1494-7. PubMed ID: 2992326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of experimental infection with pseudorabies (Aujeszky's disease) virus on pigs with maternal immunity from vaccinated sows.
    Andries K; Pensaert MB; Vandeputte J
    Am J Vet Res; 1978 Aug; 39(8):1282-5. PubMed ID: 211882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal vaccination of pigs against Aujeszky's disease: comparison with inactivated vaccines in pigs with low maternal antibody titres.
    De Leeuw PW; Van Oirschot JT
    Res Vet Sci; 1985 Jul; 39(1):34-8. PubMed ID: 2994188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a pseudorabies virus vaccine based on deletion mutant strain 783 that does not express thymidine kinase and glycoprotein I.
    van Oirschot JT; Moormann RJ; Berns AJ; Gielkens AL
    Am J Vet Res; 1991 Jul; 52(7):1056-60. PubMed ID: 1654033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination against pseudorabies with glycoprotein gI+ or glycoprotein gI- vaccine.
    Vandeputte J; Chappuis G; Fargeaud D; Précausta P; Guillemin F; Brun A; Desmettre P; Stellmann C
    Am J Vet Res; 1990 Jul; 51(7):1100-6. PubMed ID: 2167620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of various vaccination procedures on shedding, latency, and reactivation of attenuated and virulent pseudorabies virus in swine.
    Mengeling WL; Lager KM; Volz DM; Brockmeier SL
    Am J Vet Res; 1992 Nov; 53(11):2164-73. PubMed ID: 1466515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.